{{Rsnum
|rsid=1567
|Gene=NCOA7
|Chromosome=6
|position=125928768
|Orientation=plus
|GMAF=0.157
|Gene_s=NCOA7
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 2.7 | 16.8 | 80.5
| HCB | 8.0 | 33.6 | 58.4
| JPT | 1.8 | 30.1 | 68.1
| YRI | 4.9 | 34.0 | 61.1
| ASW | 3.5 | 31.6 | 64.9
| CHB | 8.0 | 33.6 | 58.4
| CHD | 3.7 | 35.8 | 60.6
| GIH | 0.0 | 5.0 | 95.0
| LWK | 9.1 | 34.5 | 56.4
| MEX | 0.0 | 13.8 | 86.2
| MKK | 14.2 | 43.9 | 41.9
| TSI | 1.0 | 24.5 | 74.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=22740868
|Title=A polymorphism in the nuclear receptor coactivator 7 gene and breast cancer susceptibility
|OA=1
}}

{{GET Evidence
|gene=NCOA7
|aa_change=Asp942Glu
|aa_change_short=D942E
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1567
|overall_frequency_n=1856
|overall_frequency_d=10758
|overall_frequency=0.172523
|n_genomes=23
|n_genomes_annotated=0
|n_haplomes=25
|n_articles=0
|n_articles_annotated=0
|nblosum100=-2
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}